A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies (Q73616916)
Jump to navigation
Jump to search
scientific article published on 01 April 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies |
scientific article published on 01 April 2000 |
Statements
A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies (English)
Demirer T
Ilhan O
Mandel NM
Arat M
Günel N
Celebi H
Ustün C
Akan H
Demirer S
Aydintuğ S
Uysal A